Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPASALT: Natriuretic Effect of Dapagliflozin in T2DM with Impaired Renal Function
NCT04620590Phase 4Completed
- Sponsor
- Emerald Clinical
- Start
- Apr 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Emerald Clinical. Started Apr 2021; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04620590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04620590.